Detail akcie Neogen Corp online

Business Summary: Neogen Corporation and subsidiaries is engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company operates in two segments: Food Safety and Animal Safety. The Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. The Animal Safety segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, cleaners, biosecurity products and genomics testing services for the worldwide animal safety market.
Financial Summary: BRIEF: For the nine months ended 28 February 2025, Neogen Corp revenues decreased 3% to $669.2M. Net loss increased from $4M to $479.8M. Revenues reflect Food Safety segment decrease of 2% to $476.3M, Animal Safety segment decrease of 3% to $192.9M, Domestic segment decrease of 4% to $333.5M, International segment decrease of 1% to $335.7M. Higher net loss reflects Food Safety segment loss totaling $399.6M vs. income of $62.5M.